SPO75 Antibody

Shipped with Ice Packs
In Stock

Description

SPO75 Protein Context

SPO75 (Sporulation 75) is a meiosis-specific protein in Saccharomyces cerevisiae (budding yeast) with the following characteristics:

  • Function: Required for spore wall formation during sporulation .

  • Genetic Interactions: Exhibits positive genetic interactions with AIM18 (a mitochondrial protein involved in redox regulation) .

  • Gene Ontology: Associated with biological processes in sporulation and cellular components related to spore walls .

No references to SPO75 antibodies exist in the provided literature, suggesting it is not a characterized antibody target in mainstream immunological research.

Antibody Mechanisms Relevant to Protein Targets

While SPO75 antibodies are not described, general antibody functions pertinent to protein targeting include:

Antibody FunctionMechanism
NeutralizationBlocks pathogen/cellular targets by binding surface epitopes .
OpsonizationFlags targets for phagocytosis via Fc receptor binding .
Complement ActivationTriggers membrane attack complexes (MACs) to lyse cells .

Antibodies against yeast proteins typically serve research tools (e.g., studying sporulation), but no such applications are documented for SPO75.

Research Gaps and Limitations

  • No Therapeutic or Clinical Data: SPO75 is not listed in therapeutic antibody databases (e.g., TABS) or immunogenicity studies .

  • Yeast-Specific Role: SPO75's role is confined to yeast sporulation, with no evidence of homologs in humans or relevance to human diseases .

Recommendations for Further Inquiry

To investigate "SPO75 Antibody" hypothetically:

  1. Yeast Proteome Studies: Use anti-SPO75 antibodies (if commercially developed) to visualize spore wall dynamics via immunofluorescence.

  2. Structural Analysis: Map SPO75 epitopes using techniques like X-ray crystallography or cryo-EM, analogous to SARS-CoV-2 spike protein studies .

  3. Genetic Interaction Profiling: Leverage BioGRID data to explore SPO75’s interactome under antibody perturbation.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPO75 antibody; YLL005C antibody; L1361 antibody; Sporulation-specific protein 75 antibody
Target Names
SPO75
Uniprot No.

Target Background

Function
SPO75 Antibody targets a protein that functions as an osmosensitive calcium-permeable cation channel. This protein is essential for spore wall assembly and ascus formation.
Database Links

KEGG: sce:YLL005C

STRING: 4932.YLL005C

Protein Families
CSC1 (TC 1.A.17) family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is SPO75 and why would researchers develop antibodies against it?

SPO75 (YLL005C) is a meiosis-specific protein found in Saccharomyces cerevisiae that is required for spore wall formation during sporulation but dispensable for both nuclear divisions during meiosis . Developing antibodies against SPO75 serves several critical research purposes:

  • Detecting and quantifying native SPO75 protein expression during different phases of sporulation

  • Investigating subcellular localization patterns using immunofluorescence microscopy

  • Identifying protein interaction partners through co-immunoprecipitation experiments

  • Validating genetic knockout or knockdown models

  • Studying potential post-translational modifications that may regulate SPO75 activity

The protein's role in spore morphogenesis makes it a valuable target for understanding the molecular mechanisms governing fungal sporulation, with potential implications for antifungal research and comparative studies of cell differentiation processes.

What are the optimal strategies for generating specific SPO75 antibodies?

Generating specific antibodies against yeast proteins like SPO75 presents unique challenges that require specialized approaches:

  • Peptide selection: Choose multiple peptide sequences (15-20 amino acids) from regions unique to SPO75, preferably from hydrophilic, surface-exposed domains. Avoid transmembrane regions and sequences with homology to other yeast proteins.

  • Recombinant protein production: Express full-length or domain-specific SPO75 constructs in bacterial systems with appropriate solubility tags (MBP, GST) to preserve native folding.

  • Host selection: Generate antibodies in hosts phylogenetically distant from yeast to maximize immunogenicity. Rabbits typically provide strong responses against yeast proteins.

  • Screening methodology: Implement a multi-tiered screening approach testing reactivity against both the immunizing antigen and native SPO75 in sporulating yeast lysates.

  • Validation controls: Always validate using SPO75 deletion strains as negative controls and epitope-tagged SPO75 strains as positive controls.

This comprehensive strategy maximizes the likelihood of generating antibodies with high specificity and sensitivity for detecting SPO75 in various experimental contexts.

What validation experiments are essential before using SPO75 antibodies in research?

Rigorous validation is crucial before employing SPO75 antibodies in research applications:

  • Western blot validation:

    • Compare signal between wild-type and spo75Δ mutant strains during vegetative growth and sporulation

    • Verify single band of appropriate molecular weight (~75 kDa)

    • Test antibody specificity across different extraction methods (native vs. denaturing)

  • Immunoprecipitation efficacy:

    • Confirm ability to immunoprecipitate SPO75 from sporulating yeast lysates

    • Verify absence of signal in spo75Δ control samples

    • Validate retrieval of known interaction partners like UTP10

  • Immunofluorescence specificity:

    • Compare staining patterns between wild-type and spo75Δ strains

    • Verify meiosis-specific expression pattern

    • Confirm co-localization with markers of structures where SPO75 is expected to function

  • Cross-reactivity assessment:

    • Test reactivity against closely related sporulation proteins

    • Perform peptide competition assays to confirm epitope specificity

    • Evaluate reactivity in other yeast species if cross-species applications are intended

These validation steps ensure experimental reliability and reproducibility in subsequent SPO75 research.

How should researchers troubleshoot weak or absent signal when using SPO75 antibodies?

When facing weak or absent SPO75 antibody signals, systematic troubleshooting approaches should include:

  • Sample preparation optimization:

    • Ensure samples are collected during appropriate sporulation timepoints when SPO75 is maximally expressed

    • Implement protease inhibitor cocktails optimized for yeast proteins

    • Test different lysis methods (mechanical disruption vs. enzymatic lysis)

    • Compare native versus denaturing extraction conditions

  • Antibody application refinement:

    • Titrate antibody concentrations across a wider range (1:100 to 1:10,000)

    • Extend primary antibody incubation times (overnight at 4°C)

    • Test different blocking agents (BSA, casein, normal serum)

    • Apply signal enhancement systems (tyramide signal amplification, poly-HRP)

  • Protocol modifications:

    • For western blotting: adjust transfer conditions, try different membrane types

    • For immunofluorescence: optimize fixation protocols, test antigen retrieval methods

    • For immunoprecipitation: modify buffer conditions, adjust bead volumes

  • Epitope accessibility assessment:

    • Consider whether post-translational modifications might mask the epitope

    • Test multiple antibodies targeting different regions of SPO75

    • Apply mild denaturation steps that might expose hidden epitopes

These systematic approaches help distinguish between technical issues and biological realities regarding SPO75 expression and detection.

How can SPO75 antibodies be optimized for studying protein-protein interactions during meiosis?

Optimizing SPO75 antibodies for protein interaction studies requires specialized techniques:

  • Cross-linking optimization:

    • Test gradient fixation with formaldehyde (0.1-3%) to preserve transient interactions

    • Implement DSS or DTSSP cross-linkers for capturing interactions via lysine residues

    • Verify that cross-linking doesn't mask antibody epitopes through comparative studies

  • Co-immunoprecipitation enhancement:

    • Develop buffer systems containing mild detergents (0.1% NP-40 or Digitonin)

    • Adjust salt concentrations (50-300mM) to balance specificity and interaction preservation

    • Test two-step immunoprecipitation protocols for increased purity

  • Proximity labeling applications:

    • Generate SPO75-BioID or SPO75-TurboID fusion constructs

    • Validate constructs using SPO75 antibodies to confirm proper expression/localization

    • Optimize biotin pulse timing to match specific meiotic stages

  • Reciprocal validation strategies:

    • Confirm interactions through reverse co-IP with antibodies against putative partners

    • Implement yeast two-hybrid or split-protein complementation assays as orthogonal validation

    • Use SPO75 antibodies to verify interaction partners identified through mass spectrometry

These optimizations enhance the ability to capture physiologically relevant SPO75 interaction networks during dynamic meiotic processes, similar to approaches used in studying other protein complexes .

What are the most effective protocols for using SPO75 antibodies in quantitative proteomics workflows?

Integrating SPO75 antibodies into quantitative proteomics requires specialized workflows:

  • Immunoprecipitation-mass spectrometry (IP-MS) optimization:

    • Minimize antibody contamination through chemical cross-linking to beads

    • Implement stringent washing protocols to reduce background

    • Elute with peptide competition rather than denaturing buffers when possible

    • Include isotope-labeled reference peptides for SPO75 and key interactors

  • Sequential purification strategies:

    • Develop tandem purification approaches (antibody-based followed by affinity tag)

    • Optimize salt and detergent gradients between purification steps

    • Maintain native conditions until final elution for interaction preservation

  • SILAC or TMT labeling compatibility:

    • Validate that immunoprecipitation efficiency is unaffected by isotope labels

    • Develop mixing protocols that minimize variability between replicate experiments

    • Create reference standard mixtures for normalization across experimental batches

  • Data analysis considerations:

    • Establish appropriate statistical thresholds for interaction significance

    • Implement stoichiometry calculations using normalized spectral counts

    • Apply computational filters to remove common contaminants in yeast IP-MS experiments

These approaches enable precise quantification of SPO75 interactions across different physiological states and meiotic stages, providing insights into its dynamic role during sporulation.

How can researchers develop phospho-specific antibodies to study SPO75 regulation?

Developing phospho-specific antibodies for SPO75 requires a systematic approach:

  • Phosphorylation site identification:

    • Perform phosphoproteomic analysis of immunoprecipitated SPO75 during sporulation

    • Use bioinformatic tools to predict kinase recognition motifs within SPO75

    • Prioritize evolutionarily conserved phosphorylation sites

  • Phosphopeptide design:

    • Synthesize peptides containing the phosphorylated residue centrally positioned

    • Include 8-10 flanking amino acids on each side to ensure context recognition

    • Generate both phosphorylated and non-phosphorylated versions of the same peptide

  • Immunization and screening strategy:

    • Implement a dual-purification approach: positive selection with phosphopeptide followed by negative selection against non-phosphorylated peptide

    • Screen with ELISA against both phosphorylated and non-phosphorylated peptides

    • Confirm phospho-specificity through western blots with phosphatase-treated samples

  • Validation in cellular context:

    • Generate phosphomimetic (S/T→D/E) and phospho-dead (S/T→A) mutants of SPO75

    • Compare antibody reactivity in wild-type versus mutant strains

    • Characterize phosphorylation dynamics during sporulation progression

This approach draws on established methodologies for developing phospho-specific antibodies like those for p-ASK1 (recognizing Ser83 phosphorylation) , adapted to the specific challenges of yeast sporulation proteins.

What experimental design is optimal for using SPO75 antibodies in super-resolution microscopy?

Implementing SPO75 antibodies in super-resolution microscopy requires careful optimization:

  • Sample preparation refinement:

    • Test fixation methods (formaldehyde, methanol, glyoxal) for optimal epitope preservation

    • Optimize cell wall digestion parameters for complete antibody accessibility

    • Implement fluorophore selection based on photophysical properties (photostability, switching kinetics)

  • Antibody format optimization:

    • Generate Fab fragments for reduced linkage error

    • Test direct fluorophore conjugation vs. secondary antibody detection

    • Optimize fluorophore-to-protein ratios to prevent self-quenching

  • Imaging parameters:

    • For STORM/PALM: Determine optimal activation densities and buffer compositions

    • For STED: Optimize depletion laser power and timing to balance resolution and photobleaching

    • For SIM: Establish pattern rotation schemes and reconstruction parameters

  • Validation methodology:

    • Implement fiducial markers for drift correction

    • Perform two-color imaging with known markers of spore wall components

    • Validate biological findings using complementary approaches (electron microscopy, biochemical fractionation)

  • Quantitative analysis workflow:

    • Develop cluster analysis algorithms appropriate for SPO75 distribution

    • Implement co-localization analysis at nanometer precision

    • Apply temporal super-resolution to track SPO75 dynamics during sporulation

These approaches will enable visualization of SPO75 localization with unprecedented precision, revealing potential nanodomains and dynamic reorganization during spore wall formation.

What statistical approaches are recommended for analyzing SPO75 antibody signals across different sporulation stages?

Rigorous statistical analysis of SPO75 signals requires specialized approaches:

  • Time-course quantification:

    • Implement mixed-effects models to account for biological and technical variability

    • Apply time-series analysis methods to characterize expression dynamics

    • Use bootstrapping approaches to establish confidence intervals for measurements

  • Single-cell analysis considerations:

    • Account for cell population heterogeneity through mixture modeling

    • Implement kernel density estimation for distribution comparisons

    • Apply machine learning classification for sporulation stage identification

  • Image analysis quantification:

    • Develop automated segmentation algorithms for yeast cells and ascospores

    • Implement intensity normalization against internal standards

    • Quantify spatial distribution patterns through radial profile analysis

  • Sample size determination:

    • Perform power analysis based on preliminary data to determine required sample sizes

    • Establish reproducibility criteria requiring consistent results across multiple experiments

    • Implement technical and biological replication strategies appropriate for each assay type

Analysis TypeRecommended Statistical TestMinimum Sample SizeKey Considerations
Western Blot QuantificationANOVA with post-hoc testsn=3 biological replicatesInclude loading controls, normalize to total protein
ImmunofluorescenceKolmogorov-Smirnov testn=100 cells per conditionAccount for cell-to-cell variability
Co-localizationPearson's correlation with randomizationn=30 cellsControl for chromatic aberration
Time-course AnalysisMixed-effects modelsn=5 timepointsAccount for experiment batch effects

These statistical approaches ensure robust, reproducible analysis of SPO75 antibody data across experimental contexts.

How should researchers interpret unexpected cross-reactivity of SPO75 antibodies with other proteins?

Cross-reactivity requires systematic investigation and interpretation:

  • Identity confirmation approaches:

    • Perform mass spectrometry identification of all bands/signals detected by the antibody

    • Compare signal patterns in wild-type versus spo75Δ strains

    • Conduct epitope mapping to identify the specific recognition sequence

  • Biological relationship assessment:

    • Investigate whether cross-reactive proteins share sequence homology with SPO75

    • Evaluate if cross-reactive proteins are functionally related to SPO75 (part of the same complex or pathway)

    • Consider whether the cross-reactivity reveals previously unknown protein family relationships

  • Technical mitigation strategies:

    • Implement competitive blocking with recombinant SPO75 or immunizing peptide

    • Use increased washing stringency to reduce low-affinity cross-reactions

    • Consider affinity purification of antibodies against recombinant SPO75

  • Experimental design adjustment:

    • Include appropriate controls in all experiments to distinguish specific from cross-reactive signals

    • Use orthogonal detection methods to confirm key findings

    • Consider generating new antibodies targeting different epitopes

Cross-reactivity, while challenging, can sometimes reveal unexpected biological insights about protein families or shared epitopes that may have functional significance in the sporulation process.

What approaches can resolve contradictions between antibody-based studies and genetic analyses of SPO75?

Resolving contradictions between different experimental approaches requires systematic investigation:

  • Timing considerations:

    • Examine whether genetic knockouts allow compensatory mechanisms to develop

    • Compare acute (antibody neutralization) versus chronic (genetic deletion) loss of function

    • Analyze temporal dynamics in both approaches with fine-grained time resolution

  • Protein function analysis:

    • Consider whether antibodies might block specific functions while preserving others

    • Evaluate if genetic manipulations produce truncated proteins with residual function

    • Use domain-specific antibodies to determine if contradictions relate to specific protein regions

  • Technical validation:

    • Confirm genetic manipulation efficiency through RT-PCR and western blotting

    • Validate antibody specificity through multiple complementary approaches

    • Develop quantitative assays to compare the degree of functional inhibition between approaches

  • Integration strategies:

    • Develop mathematical models that might explain apparent contradictions

    • Design experiments that directly compare both approaches in the same study

    • Consider combinatorial approaches (e.g., antibody treatment of partial knockdown strains)

These systematic approaches can transform apparent contradictions into deeper mechanistic insights about SPO75 function and regulation during sporulation.

How can SPO75 antibodies be utilized to investigate the spatiotemporal dynamics of spore wall assembly?

Advanced imaging applications for studying spore wall assembly include:

  • Live-cell imaging approaches:

    • Develop cell-permeable labeled nanobodies derived from SPO75 antibodies

    • Validate with fixed-cell immunofluorescence using conventional SPO75 antibodies

    • Implement lattice light-sheet microscopy for reduced phototoxicity during long-term imaging

  • Multi-color imaging strategies:

    • Label multiple spore wall components simultaneously using spectrally distinct fluorophores

    • Implement spectral unmixing for closely overlapping signals

    • Correlate SPO75 localization with other meiotic markers and spore wall components

  • Correlative light-electron microscopy:

    • Use SPO75 antibodies with gold-conjugated secondary antibodies for EM localization

    • Develop protocols for correlating fluorescence microscopy with electron microscopy

    • Implement cryo-electron tomography with immunogold labeling

  • Single-molecule tracking applications:

    • Convert SPO75 antibodies to Fab fragments labeled with photoactivatable fluorophores

    • Track individual molecules to analyze diffusion rates and binding kinetics

    • Determine if SPO75 exhibits confined motion at specific subcellular locations

These approaches enable unprecedented insights into how SPO75 contributes to the precise spatial and temporal orchestration of spore wall formation, revealing dynamic aspects invisible to static imaging methods.

What strategies can combine SPO75 antibodies with proteomics to map the complete interactome during sporulation?

Integrating antibody and proteomics approaches enables comprehensive interactome mapping:

  • BioID proximity labeling:

    • Generate SPO75-BioID fusion proteins and validate with SPO75 antibodies

    • Optimize biotin pulse timing to capture stage-specific interactions

    • Implement streptavidin purification followed by mass spectrometry

  • Cross-linking mass spectrometry (XL-MS):

    • Use SPO75 antibodies to enrich cross-linked complexes

    • Apply MS-cleavable cross-linkers for improved identification

    • Map interaction interfaces at amino acid resolution

  • Quantitative interaction proteomics:

    • Implement SILAC or TMT labeling to compare SPO75 interactors across sporulation stages

    • Use competition assays with excess peptide to distinguish specific from non-specific interactions

    • Apply computational methods to construct interaction networks with confidence scores

  • Validation pipeline:

    • Confirm key interactions through reciprocal immunoprecipitation

    • Visualize interactions using proximity ligation assay or FRET microscopy

    • Assess functional relevance through targeted mutagenesis of interaction interfaces

This multi-faceted approach would generate a dynamic, high-confidence SPO75 interaction network throughout sporulation, revealing how interaction partnerships change to orchestrate different aspects of spore wall assembly.

How can researchers develop SPO75 antibody-based biosensors to monitor spore formation in real-time?

Creating biosensors for real-time sporulation monitoring involves advanced antibody engineering:

  • Antibody fragment development:

    • Generate scFv or Fab fragments from SPO75 antibodies

    • Validate maintained specificity and affinity using standard assays

    • Optimize expression in yeast-compatible systems

  • FRET-based sensor design:

    • Create fusion constructs with fluorescent protein pairs (e.g., CFP-scFv-YFP)

    • Engineer sensor architecture to undergo conformational change upon SPO75 binding

    • Calibrate FRET response using recombinant SPO75 protein

  • Split-protein complementation approaches:

    • Fuse antibody fragments to split GFP, luciferase, or NanoLuc

    • Optimize fragment pairs for low background and high signal-to-noise ratio

    • Validate in vitro before testing in sporulating yeast cells

  • Delivery and expression strategies:

    • Develop cell-penetrating peptide conjugation for direct sensor delivery

    • Optimize expression constructs for appropriate timing during sporulation

    • Create stable sensor-expressing yeast strains for long-term studies

These biosensor approaches would enable unprecedented real-time monitoring of SPO75 expression, localization, and potential conformational changes during sporulation, providing insights into the dynamics of spore wall assembly.

What experimental design is needed to study potential SPO75 post-translational modifications using specific antibodies?

Investigating SPO75 post-translational modifications requires specialized approaches:

  • Modification-specific antibody development:

    • Generate antibodies against predicted phosphorylation, ubiquitination, or SUMOylation sites

    • Implement rigorous validation comparing modified versus unmodified peptides

    • Test reactivity in wild-type yeast versus strains with mutations in relevant modifying enzymes

  • Enrichment strategies:

    • Use general enrichment methods (phosphopeptide enrichment, ubiquitin remnant antibodies)

    • Perform sequential immunoprecipitation (first with modification-specific antibodies, then with SPO75 antibodies)

    • Develop SILAC-based strategies to quantify modification stoichiometry

  • Site-specific mutation validation:

    • Generate point mutations at putative modification sites

    • Compare antibody reactivity between wild-type and mutant proteins

    • Assess functional consequences of preventing specific modifications

  • Temporal dynamics characterization:

    • Perform time-course analyses throughout sporulation

    • Correlate modification patterns with specific sporulation stages

    • Identify enzymes responsible for adding/removing modifications

These approaches would reveal how post-translational modifications regulate SPO75 function during sporulation, potentially identifying new regulatory mechanisms governing spore wall formation.

What strategies can overcome the challenge of high background in yeast immunofluorescence when using SPO75 antibodies?

High background in yeast immunofluorescence requires systematic optimization:

  • Fixation and permeabilization refinement:

    • Test progressive formaldehyde concentrations (1-4%) and incubation times

    • Optimize cell wall digestion with varied zymolyase concentrations (5-100 μg/ml)

    • Implement detergent combinations (0.1% Triton X-100 with 0.05% SDS) for improved permeabilization

  • Blocking enhancement:

    • Use 5% BSA with 2% normal serum from secondary antibody host species

    • Add 0.1% gelatin to reduce non-specific binding to cell wall components

    • Pre-absorb primary antibodies with acetone powder from spo75Δ yeast

  • Antibody optimization:

    • Titrate antibody from 1:100 to 1:10,000 to identify optimal signal-to-noise ratio

    • Extend primary antibody incubation (overnight at 4°C) with more dilute solutions

    • Test direct fluorophore conjugation versus secondary antibody detection

  • Washing protocol enhancement:

    • Implement increased wash volumes (10x sample volume)

    • Extend wash durations (15-30 minutes per wash)

    • Add graduated salt concentrations (150-500 mM NaCl) in wash buffers

These optimizations can significantly improve signal-to-noise ratios, enabling clear visualization of SPO75 in yeast cells during sporulation.

How can researchers distinguish between SPO75 isoforms or degradation products in western blot analysis?

Resolving multiple SPO75-related bands requires specialized approaches:

  • Gel resolution optimization:

    • Implement gradient gels (6-12%) for improved separation

    • Use large-format gels with extended running times

    • Adjust acrylamide:bisacrylamide ratios for optimal resolution of proteins in the 70-80 kDa range

  • Sample preparation refinement:

    • Compare different lysis methods to minimize potential degradation

    • Test various protease inhibitor cocktails optimized for yeast

    • Implement phosphatase inhibitors to preserve phosphorylated forms

  • Antibody panel implementation:

    • Use multiple antibodies targeting different SPO75 epitopes

    • Develop domain-specific antibodies to map observed fragments

    • Implement epitope-tagged SPO75 constructs as size references

  • Validation experiments:

    • Perform immunoprecipitation followed by mass spectrometry to identify exact composition of each band

    • Compare band patterns in wild-type versus deletion strains expressing truncated SPO75 constructs

    • Use 2D gel electrophoresis to separate based on both size and charge

These approaches enable precise characterization of SPO75 variants, providing insights into potential proteolytic processing, alternative splicing, or post-translational modifications that may have functional significance during sporulation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.